top of page
detecting-skin-moles-under-magnifying-lamp-for-can-2023-11-27-05-19-57-utc.jpg

Targeted Therapy

What is Targeted Therapy?

There are several treatments for melanoma skin cancer, including targeted therapy and immunotherapy.

 

Targeted therapy drugs are designed to specifically target cancer cells. For melanoma, these drugs target the activity of a specific or unique feature of melanoma cancer cells. Genes are the instructions in cells for making new cells and controlling how cells behave. An abnormal change in these instructions – called a gene mutation – can cause cells to grow and divide out of control. Targeted therapy drugs are used as systemic therapy. For those patients with a BRAF mutation, there may be the option to use a combination of two oral (by mouth) drugs. When given together, these drugs can help block these proteins and stop the melanoma from growing. These drugs work only for people who have the BRAF mutation.

 

To determine if targeted therapy is an option for a patient, their tumour must be tested for a marker called BRAF. If the BRAF test shows that the tumour has the BRAF mutation, they are eligible for targeted therapy. However, if the tumour does not have the BRAF mutation, they are not eligible for targeted therapy. About half of all melanoma patients have a mutated form of code for the BRAF protein in their tumours. This is called having a BRAF mutation.

​

We have compiled a selection of helpful resources below.

Video Resources

 

Hear the latest updates on current immunotherapy and targeted therapy treatments for melanoma and non-melanoma skin cancers in Canada. Dr. Smylie and Dr. Iafolla hold a panel discussion on recommended dietary and lifestyle habits while on treatment, as well as managing toxicities from fever and pneumonitis to dermatologic complications from IO and Targeted Therapies.

​

​

Online Resources
Accessing Treatment Options: A Guide to Canadian Drug Formularies and Immunotherapy/BRAF Inhibitor Therapies

An up-to-date list of available treatments can be found on the Canadian Agency for Drugs and Technologies in Health (CADTH) website’s Provincial drug formulary database, which can be accessed here. For more information about immunotherapy and BRAF inhibitor therapies and whether they might be an option for you, ask your Doctor.


Listed above are a few sources of information and support you might find useful. These groups are not connected to Save Your Skin Foundation. We are providing the links as useful sources of information but do not monitor content for accuracy and quality.

 

NOTE: The information on the Save Your Skin website is not intended to replace the medical advice of a doctor or healthcare provider. While we make every effort to ensure that the information on our site is as current as possible, please note that information and statistics are subject to change as new research and studies are published. 

bottom of page